Diversity, epistemic injustice and medicalization
Cortex. 2024-07-01; 176: 234-236
DOI: 10.1016/j.cortex.2024.03.003
Lire sur PubMed
1. Cortex. 2024 Jul;176:234-236. doi: 10.1016/j.cortex.2024.03.003. Epub 2024 Mar
19.
Diversity, epistemic injustice and medicalization.
Gauld C(1), Jurek L(2), Fourneret P(3).
Author information:
(1)Service de Psychopathologie du Développement de l’Enfant et de l’Adolescent,
Hospices Civils de Lyon, France; Institut des Sciences Cognitives Marc
Jeannerod, UMR 5229 CNRS & Université Claude Bernard Lyon 1, France. Electronic
address: .
(2)Department of Child and Adolescent Psychiatry, CH le Vinatier, Lyon, France;
RESHAPE, Research on Healthcare Performance, U1290 INSERM, Claude Bernard
University Lyon 1, Lyon, France.
(3)Service de Psychopathologie du Développement de l’Enfant et de l’Adolescent,
Hospices Civils de Lyon, France; Institut des Sciences Cognitives Marc
Jeannerod, UMR 5229 CNRS & Université Claude Bernard Lyon 1, France.
This Viewpoint explores challenges within the neurodiversity framework, with a
particular focus on autism, and discusses three critical aspects: the risk of
epistemic injustice, the balance between over and undermedicalization, and the
terminological complexities associated with the « neuro- » prefix. It underscores
the importance of a balanced approach that avoids overmedicalization while
providing essential support, addresses concerns about the indiscriminate use of
« neurodiverse », questions the terminology on neurodiversity, and suggests
considering a broader term like « biopsychosocial diversity ». Ultimately, this
Viewpoint advocates for a measured approach to neurodiversity, emphasizing
historical context and a diverse perspective to foster collaboration between
cognitive science and behavior research.
Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.
DOI: 10.1016/j.cortex.2024.03.003
PMID: 38580533 [Indexed for MEDLINE]
Conflict of interest statement: Declaration of competing interest The authors
declare that they have no conflict of interest.